We applied an artificial intelligence (AI) approach to a dataset of clinical and advanced multi-omic molecular features from patients with pancreatic adenocarcinoma to predict survival. The results reveal a tumor-type-agnostic platform that can identify parsimonious and robust clinical prediction biomarkers, catalyzing the vision to democratize precision oncology worldwide.

中文翻译：

---

人工智能使用多组学数据来预测胰腺癌结果

我们将人工智能 (AI) 方法应用于胰腺癌患者的临床和高级多组学分子特征数据集，以预测生存率。结果揭示了一个与肿瘤类型无关的平台，可以识别简约而强大的临床预测生物标志物，从而促进全球精准肿瘤学民主化的愿景。